FMM urges clarity, dialogue on port tariff hike
In response to the explanations provided by the Port Klang Authority (PKA) in its press statement dated June 16, 2025, FMM said given the wide-ranging implications for trade, investment and the cost of doing business, it believes the rationale for the revision warrants further scrutiny.
"FMM fully respects the right of all stakeholders, including PKA, to present and defend their positions. Constructive dialogue is essential to national development.
"However, given the wide-ranging implications of this tariff hike, especially amid broader cost escalations and global uncertainties, we believe it is time to move beyond justification and toward pragmatic resolution," said FMM president Tan Seri Datuk Soh Thian Lai.
Soh said the federation disagrees on PKA points that Port Klang's tariff rates will remain among the most competitive in the region.
While Port Klang's official handling tariff of RM390 (approximately US$92 per TEU) may appear lower on paper, he said this figure does not reflect the actual cost borne by Malaysian shippers.
"Terminal Handling Charges (THC) are not billed directly by port operators to shippers; instead, they are imposed by shipping lines, often with significant mark-ups.
"Current publicly available rates by shipping lines show that Malaysian shippers are already paying an average of RM480 per 20-foot container, well above the existing RM300 port handling charge.
"Increasing the tariff to RM390 without structural reform will effectively give shipping lines the latitude to raise THC further, potentially reaching the real-world cost range of US$120 to 130 per TEU," he said.
Meanwhile, Soh pointed out that port operators face cost pressures like other industries, but it questions whether the proposed tariff hike is truly warranted given current financial and regulatory contexts.
Under existing concession agreements, the costs associated with port development and infrastructure are contractually required to be fully borne by port operators, he said.
As for the PKA's claims that relative to other increases, port charges are a small fraction of the total cost that consumers will ultimately bear indirectly, FMM disagrees with the narrow framing of cost impact based solely on per-kilogram increments.
While PKA's micro-level calculation may appear negligible, he said it overlooks the broader and more significant issue, such as the cumulative cost burden placed on Malaysian exporters, importers and manufacturers.
"PKA's analysis fails to acknowledge that logistics costs are already among the highest contributors to the cost of doing business in Malaysia.
"The impact of a 30 per percent increase in container handling charges and a 200–243 per cent hike in storage charges cannot be minimised by simplistic per-unit cost metrics.
"FMM reiterates that the evaluation of port tariff adjustments must be done holistically, accounting for their multiplier effect across the supply chain and national economy," he said.
In addition, Soh said FMM reiterates that claims of "modest" increases are not supported by the quantum of the adjustments, which are among the steepest seen in recent memory.
Without detailed, he said, transparent cost justifications, these increases will be viewed as revenue maximisation at the expense of trade facilitation.
"Maintaining investor confidence and trade momentum requires a holistic approach where competitiveness is grounded in predictable pricing, stakeholder consultation and a transparent cost-recovery framework.
"FMM urges the authorities to defer the hike and engage the industry in reassessing a sustainable, accountable tariff structure aligned with national economic goals," he added.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
New Straits Times
29 minutes ago
- New Straits Times
Oil regains ground from two-month lows ahead of Trump-Putin meeting
TOKYO: Oil prices edged higher on Thursday, regaining ground after a sell-off in the previous session, with the upcoming meeting between US President Donald Trump and his Russian counterpart Vladimir Putin raising risk premiums in the market. Brent crude futures were up 28 cents, or 0.43 per cent, at US$65.91 a barrel at 0057 GMT, while US West Texas Intermediate crude futures rose 23 cents, or 0.37 per cent, to US$62.89. Both contracts hit their lowest in two months on Wednesday after bearish supply guidance from the US government and the International Energy Agency (IEA). Trump on Wednesday threatened "severe consequences" if Putin does not agree to peace in Ukraine. Trump did not specify what the consequences could be, but he has warned of economic sanctions if the meeting in Alaska on Friday proves fruitless. "The uncertainty of US-Russia peace talks continues to add a bullish risk premium given Russian oil buyers could face more economic pressure," Rystad Energy said in a client note. "How Ukraine-Russia crisis resolves and Russia flows change could bring some unexpected surprises." Another support for oil is that the expectation that the US Federal Reserve will cut rates in September is at close to 100 per cent after US inflation increased at a moderate pace in July. Treasury Secretary Scott Bessent said he thought an aggressive half-point cut was possible given recent weak employment numbers. The market is putting the odds of a quarter-percentage point cut at the Fed's September 16-17 meeting at 99.9 per cent, according to the CME FedWatch tool. Lower borrowing rates would drive demand for oil. The dollar was hovering near multi-week lows against the euro and sterling on Thursday as traders ramped up bets for the Fed to resume cutting interest rates next month. Oil prices were kept in check as crude inventories in the United States unexpectedly rose by 3 million barrels in the week ended on August 8, according to the US Energy Information Administration on Wednesday, against expectations in a Reuters poll for a 275,000-barrel draw. Also, holding oil back was an International Energy Agency forecast that 2025 and 2026 world oil supply would rise more rapidly than expected, as the Organisation of the Petroleum Exporting Countries and its allies, together known as OPEC+, increase output and production from outside the group grows.
New Straits Times
29 minutes ago
- New Straits Times
Dollar in doldrums as Fed rate-cut bets build
TOKYO: The dollar languished near multi-week lows against the euro and sterling on Thursday as traders ramped up bets for the Federal Reserve to resume cutting interest rates next month. Rising expectations for Fed easing combined with increasing institutional cryptocurrency investment sent bitcoin powering to a fresh record peak. The dollar index, which measures the currency against the euro, sterling and four other major peers, was steady at 97.704 as of 0002 GMT. It dropped some 0.8 per cent over the previous two sessions, having dipped to 97.626 on Wednesday for the first time since July 28. The euro edged up to US$1.1713, nearing Wednesday's high of US$1.1730, a level last seen on July 28. Sterling rose to US$1.3586 for the first time since July 24. Against Japan's currency, the greenback lost 0.3 per cent to 146.95 yen. Fed rhetoric has turned overall more dovish of late, amid signs of a cooling labour market and with President Donald Trump's tariffs not adding to price pressures in a significant way as of yet. Traders see a Fed rate cut on September 17 as a near certainty, according to LSEG data, and even lay around 7 per cent odds on a super-sized half-point reduction. "For the markets, it's not even a matter of if the Fed cuts interest rates in September, it's a question of how much," said Kyle Rodda, an analyst at "Signs of a downturn in the labour market have pushed futures to bake in a series of rate cuts before the end of the year." On Wednesday, Treasury Secretary Scott Bessent called for a "series of rate cuts," and said the Fed could kick off the policy rate easing with a half-point cut. Trump has repeatedly criticised Fed Chair Jerome Powell for not easing rates sooner. A weaker dollar, the spectre of political interference in US monetary policy, and the increase in investor risk appetite amid Fed easing prospects all converged to buoy bitcoin to its first record peak since July 14, pushing as high as US$123,674.71 in the latest session. Bitcoin was already underpinned by increased institutional money flows this year in the wake of a spate of regulatory changes spearheaded by Trump, who has billed himself the "cryptocurrency president." In the latest move, an executive order last week paved the way to allow crypto assets in 401(k) retirement accounts. "Corporate treasuries like MicroStrategy and Block Inc. continue to buy bitcoin," said IG analyst Tony Sycamore.
New Straits Times
an hour ago
- New Straits Times
US pharma tariffs likely weeks away, sources say
WASHINGTON: The announcement by President Donald Trump's administration of the results of a probe into pharmaceutical imports and new sector-specific US tariffs likely remains weeks away, four official and industry sources said, later than initially promised as he focuses on other matters. Commerce Secretary Howard Lutnick had said in April when the review of whether reliance on foreign drug production threatens US national security was launched that he anticipated that it would conclude between mid-May and mid-June. Global pharmaceutical companies are bracing for the outcome of the investigation, which will usher in sector-specific tariffs that Trump has said could start small and eventually rise to 250 per cent. The Republican president said as recently as last week that his plan relies on phased-in tariffs, giving drugmakers time to increase manufacturing in the United States as he pushes to alter what he says are global trade distortions in many industries. One government official in Europe and a source with knowledge of the White House process, as well as two sources at European drug firms familiar with the process, told Reuters that the report and tariffs announcement was not imminent and likely weeks away. These sources spoke on condition of anonymity. A White House spokesperson, asked about media reporting indicating that the results of the probe could be several weeks away, cautioned that such reports were pure speculation unless confirmed by the White House. The spokesperson declined to give further details about the timing of the pharma probe or one involving semiconductors. The investigation is examining pharmaceutical imports ranging from finished prescription drugs to active pharmaceutical ingredients, called APIs, and other raw materials, with the results to be disclosed in a Commerce Department report. Lutnick said last month the tariff plan that will be based on the report would be completed by the end of July. Lutnick then said on July 29 it would be two more weeks. The investigation was launched under Section 232 of the Trade Expansion Act of 1962. While the investigation is ongoing, the pharmaceutical sector has been exempted from the sweeping tariffs imposed by the Trump administration. The United States has reached bilateral trade deals with the UK, Japan, South Korea and the European Union that promised more favorable terms for their pharma exports than those expected to be levied on the sector globally. A European government official said that an announcement before the end of August appears unlikely but cautioned that the timeline could shift depending on other developments. A source at a European drugmaker said the Trump administration is focused on the US-Russia summit in Alaska on Friday and therefore no announcement is expected this week. The source familiar with the White House process said that announcement is unlikely to come this week given other priorities. That source and one other source said that they expect the Trump administration to announce the results of its national security investigation into semiconductors first, followed by the pharma announcement, putting it a few weeks away. The Section 232 provision authorizes the president to adjust imports - including imposing tariffs - if a category of goods is being imported into the United States in quantities that "threaten or impair the national security." Medical goods historically have been spared from trade wars due to the potential harm to patient access, and drugmakers have said tariffs could undercut other health policy goals outlined by the Trump administration, including lowering drug prices. US tariffs on imported pharmaceutical products would mark the latest in a series of sectoral tariffs announced by the administration, following metals and cars, that some economists have predicted will drive up costs for American consumers.
